Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
In this week’s Pathways Picks: FDA takes step toward mandatory electronic PMAs; congressional watchdog looks at FDA third party reviewers; an advisory panel support GRAIL’s cancer-screening PMA; FDA commissioner nominee heads to the Hill; China issues guides on AI clinical evaluation, good manufacturing practices, and real world data quality; and more medtech policy updates.
In this week’s Pathways Picks: FDA takes step toward mandatory electronic PMAs; congressional watchdog looks at FDA third party reviewers; an advisory panel support GRAIL’s cancer-screening PMA; FDA commissioner nominee heads to the Hill; China issues guides on AI clinical evaluation, good manufacturing practices, and real world data quality; and more medtech policy updates.
Whether its a guidance, regulation, white paper, classification order, or any number of other documents that make the medtech regulatory and market access world tick, look for it on Document Depot — Market Pathways' medtech policy database. Search, sort, and filter through thousands of medtech policy documents from hundreds of agencies and organizations based around the globe, see what items are open for public comment, and view linkages between document versions over time.